Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

PRIMO 2024 | Evolution of gene therapy in oncology

Manmeet Ahluwalia • 8 Mar 2024
PRIMO 2024
General

Manmeet Ahluwalia, MD, MBA, FASCO, Baptist Health Miami Cancer Institute, Kendall, FL, discusses the evolution of gene therapy in oncology, particularly focusing on CAR-T cell therapy. This interview took place at the 2024 PRIMO meeting in Honolulu, Hawaii.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Manmeet Ahluwalia

3:17
Transformative potential of CAR-T cell therapy: current challenges and future Directions
Manmeet Ahluwalia • 8 Mar 2024
2:53
Advancements and challenges in CAR-T cell therapy
Manmeet Ahluwalia • 29 Feb 2024
1:51
EQUILIBRIUM: ibrutinib with temozolomide and radiation in nGBM
Manmeet Ahluwalia • 7 Jun 2023
0:45
An overview of novel glioblastoma biomarkers
Manmeet Ahluwalia • 7 Jun 2023

Related Videos

2:03
Biomarker detection for early cancer detection
Robert Rintoul • 19 Apr 2024
0:29
Innovative ctDNA-based liquid biopsy techniques for cancer diagnosis
Alain Thierry • 9 Apr 2024
0:50
Employing fragmentomics as a novel strategy to characterize and detect cancers
Alain Thierry • 9 Apr 2024
1:27
Emerging trials in melanoma: SWOG S1801, OpACIN-neo and PRADO
Christoffer Gebhardt • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals